Autoimmune polyglandular syndrome type 1
https://doi.org/10.21886/2219-8075-2022-13-2-168-171
Abstract
Type 1 autoimmune polyglandular syndrome (APS1) is a rare disease, with an unknown prevalence in the Russian population. Due to the low awareness of doctors, it takes more time to make the accurate diagnosis and provide correct medical care. This article describes classical features of APS1 and a clinical case of a patient, who did not have one of the most common first manifestation of the disease - mucocutaneous candidiasis. Hypocalcemia was detected much later than the first clinical manifestations in the form of generalized seizures occurred. Patient also suffers from tapetoretinal abiotrophy, he completely lost vision in childhood which made it difficult for the doctor and patient to interact in the treatment of the disease.
About the Authors
T. A. KiselevaRussian Federation
Tatiana A. Kiseleva, Cand. Sci. (Med.), associate professor of the Department of Endocrinology
Kazan
F. V. Valeeva
Russian Federation
Farida V. Valeeva, Dr. Sci. (Med.), professor, the Head of the Department of Endocrinology
Kazan
D. L. Ekimovskaya
Russian Federation
Dina L. Ekimovskaya, clinical resident of the Department of endocrinology
Kazan
M. A. Makarov
Russian Federation
Maksim A. Makarov, PhD, associate professor of the Department of propaedeutics of internal diseases
Kazan
R. T. Habibullina
Russian Federation
Ramziya T. Khabibullina, deputy medical director
Kazan
References
1. Husebye ES, Anderson MS, Kämpe O. Autoimmune Polyendocrine Syndromes. N Engl J Med. 2018;378(12):1132- 1141. DOI: 10.1056/NEjMra1713301.
2. Bruserud Ø, Oftedal BE, wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8-15. DOI: 10.1016/j.coi.2016.07.003.
3. Orlova EM, Sozaeva LS, Kareva MA, Oftedal BE, wolff ASB, et al. Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1. J Clin Endocrinol Metab. 2017;102(9):3546-3556. DOI: 10.1210/jc.2017-00139.
4. Perheentupa j. Autoimmune polyendocrinopathy-candidiasisectodermal dystrophy. J Clin Endocrinol Metab. 2006;91(8):2843-50. DOI: 10.1210/jc.2005-2611.
5. Betterle C, Greggio NA, Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998;83(4):1049-55. DOI: 10.1210/jcem.83.4.4682.
6. Breunig A, Lee MS, Miller BS, Binstadt BA, Anderson MS, Montezuma S. Autoimmune retinopathy in a patient with autoimmune polyendocrine syndrome type I. Ocul Immunol Inflamm. 2013;21(2):153-7. DOI: 10.3109/09273948.2012.754906.
7. Brännström j, Hässler S, Peltonen L, Herrmann B, winqvist O. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens. Clin Immunol. 2006;121(3):265-73. DOI: 10.1016/j.clim.2006.08.005.
Review
For citations:
Kiseleva T.A., Valeeva F.V., Ekimovskaya D.L., Makarov M.A., Habibullina R.T. Autoimmune polyglandular syndrome type 1. Medical Herald of the South of Russia. 2022;13(2):168-171. (In Russ.) https://doi.org/10.21886/2219-8075-2022-13-2-168-171